STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABEV
  4. [6-K] AMBEV S.A. Current Report (Foreign Issuer)

Ambev S.A. (NYSE: ABEV) details November 2025 treasury share and restricted stock activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Ambev S.A. reported its own transactions in Ambev securities for November 2025, focusing on movements in treasury shares. The company started the month holding 169,171,789 common shares in treasury and no ADRs. During the month, it delivered 106,294 common shares as restricted shares at a reference price of R$12.91 per share, totaling R$1,372,255.54, and purchased 17,210 common shares directly from the company at R$13.77 per share, totaling R$236,981.70. After these transactions, Ambev ended November with 169,082,705 common shares in treasury and no ADRs.

Positive

  • None.

Negative

  • None.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of December, 2025

Commission File Number 1565025

 

 

AMBEV S.A.

(Exact name of registrant as specified in its charter)

 

AMBEV S.A.

(Translation of Registrant's name into English)

 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

 Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____

 
 

 

 

 

 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In November 2025:

 

(X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.(1)

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.  
Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00  
Qualification: Outstanding Shares in Treasury  
Initial Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 169,171,789  
ADR Common 0.00  
Transactions in the month  
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$)(3)  
Shares Common Direct with company Delivery of restricted shares 04 106,294 12.91 1,372,255.54  
Shares Common Direct with company Purchase 24 17,210 13.77 236,981.70  
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
Final Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 169,082,705  
ADR Common 0  
                   

 

(1)When filling in the form, delete the lines that do not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information,

(2)     Issue/Series, convertibility, simple, term, guaranties, type/class, among others,

(3)Quantity multiplied by price,

 

(*)Each ADR is equivalent to 1 (one) share,

 

 
 

SIGNATURE



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: December 8, 2025

     
  AMBEV S.A.
     
  By:  /s/ Guilherme Fleury de Figueiredo Ferraz Parolari
 

Guilherme Fleury de Figueiredo Ferraz Parolari

Chief Financial and Investor Relations Officer

Source: View Original Filing on SEC EDGAR

FAQ

What did Ambev S.A. (ABEV) disclose in this November 2025 report?

Ambev S.A. disclosed its November 2025 transactions in its own securities, detailing treasury share deliveries for restricted shares and direct share purchases, along with initial and final treasury balances.

How many Ambev (ABEV) treasury shares were delivered as restricted shares in November 2025?

Ambev delivered 106,294 common shares as restricted shares in November 2025, at a reference price of R$12.91 per share, totaling R$1,372,255.54.

How many Ambev (ABEV) shares did the company purchase in November 2025?

The company purchased 17,210 common shares directly from the company on day 24 of November 2025 at R$13.77 per share, for a total of R$236,981.70.

What was Ambev’s (ABEV) final treasury share balance at the end of November 2025?

At the end of November 2025, Ambev held 169,082,705 common shares in treasury and no ADRs, compared with 169,171,789 common shares at the beginning of the month.

Does this Ambev (ABEV) disclosure involve ADR transactions?

No. The disclosure shows that Ambev had zero ADRs in treasury at both the beginning and end of November 2025, and no ADR transactions are listed.

Who signed this Ambev S.A. (ABEV) report?

The report was signed by Guilherme Fleury de Figueiredo Ferraz Parolari, who serves as Ambev’s Chief Financial and Investor Relations Officer.